Anbio Biotechnology Class A Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-06-30 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $2,528 | $6,322 | $3,950 | $3,306 |
Gross Profit | 2,137 | 4,226 | 1,691 | 1,941 |
EBITDA | -1,324 | 3,887 | 796 | 1,652 |
EBIT | -1,735 | 3,889 | 792 | 1,643 |
Net Income | -1,324 | 3,887 | 792 | 1,643 |
Net Change In Cash | 2,528 | 6,322 | 3,950 | 3,306 |
Free Cash Flow | 1,604 | 647 | -1,331 | 2,303 |
Cash | 11,760 | 10,310 | 9,687 | 10,561 |
Basic Shares | 42,291 | 42,291 | 42,291 | 42,291 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $8,185 | $6,711 | $23,544 | $4,428 |
Gross Profit | 5,885 | 3,360 | 12,563 | 2,541 |
EBITDA | 2,566 | 2,449 | 10,025 | 2,535 |
EBIT | 1,995 | 2,436 | 10,019 | 2,455 |
Net Income | 2,372 | 2,253 | 10,011 | 2,535 |
Net Change In Cash | 8,185 | 6,711 | 23,544 | 4,428 |
Free Cash Flow | 2,080 | 898 | 4,448 | 4,181 |
Cash | 11,760 | 9,687 | 7,102 | 4,181 |
Basic Shares | 42,291 | 187,782 | 143,891 | 100,000 |
